November #159 : Medicine Chest

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Who Wants to Be an AIDS Advocate?

Let’s Get Ready to Rally!




When Pigs Fly

Just the Facts, Ma’am

Breath of Life?

Staying Alive

Medicine Chest

Need a Doctor? Call a Nurse.

D-Ficiency

Dollar Days

Booty Boost




Take Home Testing

Inglourious Adsters?

Show Us the Money

Acting Up

The Defense Rests

Healthy Debate




Editor's Letter-November 2009

The Power of 'U'



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

November 2009


Medicine Chest

Intelence Warning
Intelence (etravirine, a non-nuke) may, in rare cases, cause a serious rash. This can be linked to a hypersensitivity reaction including flulike symptoms and sometimes organ failure. If you’ve recently started Intelence and you develop a rash, contact your doctor about possibly discontinuing the drug. Updated prescribing information for Intelence says the reaction has generally appeared within six weeks of beginning the drug.

Isentress is now available for first timers
People taking HIV meds for the first time can now include Isentress (raltegravir) in their combo, the FDA says. In 2007, Isentress was approved only for people who’d been on most other available HIV meds. The dose of this integrase inhibitor is the same for both groups: a 400 mg tablet twice daily in a multidrug regimen.    

Search: etravirine, rash, hypersensitivity, symptoms, Intelence, Isentress, HIV, meds


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    adoniz89
    san dimas
    California


    koffeeboss
    Tucson
    Arizona


    youngbloodlatino
    Columbia
    Maryland


    kmfdm221
    Arcata
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.